Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, we performed BMD measurement combined with vertebral fracture assessment (VFA) by DXA for the postmenopausal women receiving the first bone densitometry and studied the impact of VFA on the diagnosis of osteoporosis.
|
31352490 |
2020 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Altogether, 126 postmenopausal women belonging to four different groups were included: healthy (n=42), low BMD and no vertebral fractures (n=39), vertebral fractures and low BMD without a treatment (n=26), or receiving a treatment for osteoporosis (n=19).
|
31669252 |
2020 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Using the T-score approach our aims were to: i) investigate the effects of oral nitrogen-containing bisphosphonates on bone balance and turnover in postmenopausal women with osteoporosis and ii) determine the relationship of the change in bone balance and turnover with the change in BMD at the lumbar spine and total hip.
|
31740343 |
2020 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
To compare associations of current and past self-reported bone-specific physical activity, and current accelerometer-determined physical activity (PA), with bone structure (bone mineral density [BMD] and microarchitecture) in postmenopausal women with osteopenia or osteoporosis.
|
31720706 |
2020 |
Osteoporosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
BMD measurements and kidney function for risk prediction were also evaluated; women were categorized by both reduced kidney function (stages 3-5) and osteoporosis status.
|
31754754 |
2020 |
Osteoporosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The objectives of this study are to assess the correlation between BMD and serum lipid levels, to determine independent variables associated with osteoporosis and osteopenia in men and postmenopausal women with type 2 diabetes (T2D).
|
30235494 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The diagnosis of osteoporosis is intimately linked with the imaging and quantification of bone and BMD.
|
31189982 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The purpose of our study is to examine the association between LTL, and BMD and osteoporosis among an elderly Chinese population.
|
31025211 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
This prospective study examined the effects of once-weekly teriparatide treatment on the serum levels of sclerostin, osteocalcin, and bone formation markers as well as BMD of the lumbar spine and femoral neck in 32 postmenopausal women with osteoporosis.
|
30573396 |
2019 |
Osteoporosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A number of studies investigated the distribution of BMD values and the prevalence of osteoporosis in China, but their findings varied.
|
31067339 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The medical history, anthropometric data, lumbar and femoral BMD (DXA) [considering osteoporosis (OP): T-score ⩽-2.5], TBS (considering degraded microarchitecture: <1.230) and dorsolumbar X-ray [to assess vertebral fractures (VF)] were evaluated.
|
31628810 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Retrospective, observational cohort study using Swedish national health register data and BMD data from osteoporosis clinics.
|
30963310 |
2019 |
Osteoporosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This study included 128 patients with osteoporosis (BMD T-score -3.2±1.9; range, -5.4 to -2.5) who underwent spinal decompression and instrumentation with a polymethylmethacrylate-augmented bone cement-injectable cannulated pedicle screw.
|
31188908 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The cost-effectiveness of preventive alendronate therapy for postmenopausal women with osteopenia or osteoporosis using GC is sensitive to age, BMD, GC dose, and the presence of previous fracture.
|
30610244 |
2019 |
Osteoporosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The levels of OC were significantly different in women with osteopenia and osteoporosis (ANOVA, p < .0001) compared to women with normal BMD.
|
30537473 |
2019 |
Osteoporosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Faecal microbiota profiles were determined from 181 individuals with osteopenia (n = 61) or osteoporosis (n = 60), and an age- and gender-matched group with normal BMD (n = 60).
|
31378815 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Since BMD was proved to be highly heritable, based on a comprehensive genome-wide meta-analysis that reported 63 BMD-related single nucleotide polymorphisms (SNPs), we aim to unravel the overall genetic risk for decreased BMD and osteoporosis in African-American women.
|
31786628 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Despite normal areal BMD values assessed by dual-energy X-ray absorptiometry and no family history of osteoporosis, the patient demonstrated low lumbar spine trabecular bone score, as well as low peripheral trabecular volumetric BMD and deterioration of trabecular microarchitecture assessed by high-resolution peripheral quantitative computed tomography.
|
31273389 |
2019 |
Osteoporosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
As he continued to run over the following 2 years, his mileage threshold to fracture steadily and rapidly decreased until he was diagnosed with severe osteoporosis (lumbar spine BMD Z-score of -3.2).
|
30972028 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
A total 24 texture features demonstrated statistically significant differences between normal BMD and osteoporosis in the left sphenoid and a total of 31 texture features in the left condyle.
|
31153568 |
2019 |
Osteoporosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Data from human diseases or dysfunctions identified 19 genes whose mutation was associated with human BMD: 9 genes each for human height and osteoporosis; 4 genes each for human osteoarthritis (OA) and fracture risk; and 2 genes each for adolescent idiopathic scoliosis (AIS), periodontitis, osteosarcoma growth, and tooth development.
|
31646011 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We divided our population into 5 groups with different phenotypes characterizing the severity of the disease and/or the severity of bone involvement: 1 - Normal BMD and body mass index (BMI): recovery from AN; 2 - Osteopenia (-2<Z-score<-1) and BMI>17kg/m<sup>2</sup>; 3 - Osteopenia and BMI≤17kg/m<sup>2</sup>; 4 - Osteoporosis (Z-score≤-2) and BMI>17kg/m<sup>2</sup>; 5 - Osteoporosis and BMI≤17kg/m<sup>2</sup>.
|
29653285 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study estimated normative BMD and TBS reference data for women aged 20-70 in Sri Lanka and the effect of local reference data on the diagnosis of osteoporosis among postmenopausal women.
|
31432256 |
2019 |
Osteoporosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
BMD (classified according to the WHO criteria for osteoporosis) of the hip and lumbar spine, the VFx (classified as a Genant score >1/>20% height loss), and radiological progression (modified stoke ankylosing spondylitis spinal score [mSASSS]) scores were obtained at baseline and at 4 years of TNFi treatment.Overall, 135 AS patients were included.
|
30690799 |
2019 |
Osteoporosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A once-weekly pill containing risedronate and cholecalciferol had the equivalent antiresorptive efficacy on BMD compared with risedronate alone and improved 25(OH) D serum levels after 12 months of treatment without significant adverse events in Korean patients with osteoporosis.
|
31820121 |
2019 |